Prevalence of conditions causing chronic anovulation and the proposed algorithm for anovulation evaluation

Journal of Obstetrics and Gynaecology Research

Volumn , Issue , 2015, Pages 1074-1079

  Chandeying, Pitch ^a   Pantasri, Tawiwan ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

amenorrhea; anovulation; congenital adrenal hyperplasia; oligomenorrhea; polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE;

ADRENAL TUMOR; ADULT; ALGORITHM; ANDROSTENEDIONE BLOOD LEVEL; ANOVULATION; ARTICLE; CLINICAL EVALUATION; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CUSHING DISEASE; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PELVIS RADIOGRAPHY; PREVALENCE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TESTOSTERONE BLOOD LEVEL; THYROID DISEASE;

EID: 84984633493     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12685     Document Type: Article

References (23)

1. Hahn KA, Wise LA, Riis AH et al. Correlates of menstrual cycle characteristics among nulliparous Danish women. Clin Epidemiol 2013; 5: 311–319.
2. Hamilton-Fairley D, Taylor A. Anovulation. BMJ 2003; 327: 546–549.
3. Li RH, Ng EH. Management of anovulatory infertility. Best Pract Res Clin Obstet Gynaecol 2012; 12: 757–768.
4. Practice Committee of American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2008; 90 (5 Suppl): S219–S225.
5. Pantasri T, Vutyavanich T, Sreshthaputra O, Srisupundit K, Piromlertamorn W. Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome. J Med Assoc Thai 2010; 93: 406–412.
6. Morley JE, Patrick P, Perry HM 3rd. Evaluation of assays available to measure free testosterone. Metabolism 2002; 51: 554–559.
7. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47.
8. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries – A common finding in normal women. Lancet 1988; 1: 870–872.
9. Azziz R, Carmina E, Dewailly D et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril 2009; 91: 456–488.
10. Bahamondes L, Faundes A, Tambascia M, Trevisan M, Dachs JN, Pinotti JA. Menstrual pattern and ovarian function in women with hyperprolactinemia. Int J Gynaecol Obstet 1985; 23: 31–36.
11. Ylostalo P, Kujala P, Kontula K. Amenorrhea with low normal thyroid function and thyroxine treatment. Int J Gynaecol Obstet 1980; 18: 176–180.
12. Essah PA, Wickham EP 3rd, Nunley JR, Nestler JE. Dermatology of androgen-related disorders. Clin Dermatol 2006; 24: 289–298.
13. Bode D, Seehusen DA, Baird D. Hirsutism in women. Am Fam Physician 2012; 85: 373–380.
14. Cheewadhanaraks S, Peeyananjarassri K, Choksuchat C. Clinical diagnosis of hirsutism in Thai women. J Med Assoc Thai 2004; 87: 459–463.
15. Somani N, Harrison S, Bergfeld WF. The clinical evaluation of hirsutism. Dermatol Ther 2008; 21: 376–391.
16. Zhao X, Ni R, Li L et al. Defining hirsutism in Chinese women: A cross-sectional study. Fertil Steril 2011; 96: 792–796.
17. Pang S, Murphey W, Levine LS et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab 1982; 55: 413–420.
18. Lee HH, Kuo JM, Chao HT et al. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese. J Clin Endocrinol Metab 2000; 85: 597–600.
19. Cutfield WS, Webster D. Newborn screening for congenital adrenal hyperplasia in New Zealand. J Pediatr 1995; 126: 118–121.
20. Pang S, Spence DA, New MI. Newborn screening for congenital adrenal hyperplasia with special reference to screening in Alaska. Ann N Y Acad Sci 1985; 458: 90–102.
21. Hendriks ML, Brouwer J, Hompes PG, Homburg R, Lambalk CB. LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea. Reprod Biomed Online 2008; 16: 765–771.
22. Banaszewska B, Spaczynski RZ, Pelesz M, Pawelczyk L. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. Rocz Akad Med Bialymst 2003; 48: 131–134.
23. Cho LW, Jayagopal V, Kilpatrick ES, Holding S, Atkin SL. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome. Ann Clin Biochem 2006; 43 (Pt 3): 217–219.